1-4 of 4
neurotoxic agents
Close
Sort by
Journal Articles

Prevalence and Predictors of Self-Reported Neuropsychological Impairment in Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Impact On Return to Work After HCT.

Alysia Bosworth, Lennie Wong, Sunita Patel, Doojduen Villaluna, Mitzi Gonzales, Marcia Grant, Stephen J. Forman, Smita Bhatia
Journal: Blood
Blood (2009) 114 (22): 808.
https://doi.org/10.1182/blood.V114.22.808.808
Published: 2009
Journal Articles

Neurocognitive Function and Its Impact On Return to Work in Patients Treated with Hematopoietic Cell Transplantation (HCT).

F. Lennie Wong, PhD, Alysia Bosworth, Rose Danao, Doojduen Villaluna, MS, Sunita Patel, PhD, Marcia Grant, RN, DNSc, FAAN, Stephen J Forman, MD, Smita Bhatia, MD, MPH
Journal: Blood
Blood (2009) 114 (22): 521.
https://doi.org/10.1182/blood.V114.22.521.521
Published: 2009
Journal Articles

VAMP/ThaCyDex: Velcade® (Bortezomib), Adriamycin, Melphalan and Prednisone Alternating with Thalidomide, Cyclophosphamide and Dexametasone as a Salvage Regimen in Relapsed Multiple Myeloma Patients

Enrique Colado, MD, Maria-Victoria Mateos, MD, PhD, Maria-Jose Moreno, MD, Felipe de Arriba, MD, Javier de la Rubia, MD, Juan José Lahuerta, MD, PhD, Pastora Iniesta, MD, Maria Cruz Viguria, MD, Ana Pilar Gonzalez, MD, Ramón García-Sanz, MD, PhD, Juan Olazabal, MD, Jesús F San Miguel
Journal: Blood
Blood (2008) 112 (11): 3694.
https://doi.org/10.1182/blood.V112.11.3694.3694
Published: 2008
Journal Articles

Marqibo (Vincristine Sulfate Liposomes Injection (OPTISOME™) Demonstrates Activity in Patients with Relapsed and Refractory Peripheral T-Cell Lymphoma.

M. Alma Rodriguez, MD, Jane N. Winter, MD, Biao Lu, PhD, Gary Huang, MD, Gavin S. Choy, PharmD, Steven R. Deitcher, MD
Journal: Blood
Blood (2007) 110 (11): 4466.
https://doi.org/10.1182/blood.V110.11.4466.4466
Published: 2007